{"address1": "Suzhou Industrial Park", "address2": "68 Xinqing Road", "city": "Suzhou", "zip": "215000", "country": "China", "phone": "86 512 8555 7777", "website": "https://www.ascentage.cn", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for the treatment of small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumor, and non-Hodgkin's lymphoma. In addition, the company is developing APG-1387, a small molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection; APG-2449, an oral inhibitor of FAK, ROS1, and ALK kinases; APG-5918, an orally available and selective embryonic ectoderm development inhibitor; APG-265, a MDM2 protein degrader; and UBX1967/1325, which are Bcl-2 inhibitors. In addition, it is also involved in medical research and development; clinical development; clinical trial operation; venture capital investment; rental services; and science and technology promotion services. The company has collaboration relationships with biotechnology and pharmaceutical companies; and research institutions. Ascentage Pharma Group International was founded in 2009 and is headquartered in Suzhou, China.", "fullTimeEmployees": 567, "companyOfficers": [{"maxAge": 1, "name": "Dr. Dajun  Yang M.D., Ph.D.", "age": 61, "title": "Co-Founder, Chairman & CEO", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 577240, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shaomeng  Wang Ph.D.", "age": 59, "title": "Co-Founder, Chief Scientific Advisor & Non-Executive Director", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 162288, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ming  Guo", "age": 66, "title": "Co-Founder", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jin  Cao", "age": 38, "title": "Head of Finance", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas Joseph  Knapp J.D.", "age": 71, "title": "Senior VP & General Counsel", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yifan  Zhai M.D., Ph.D.", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raymond Jeffrey  Kmetz", "age": 65, "title": "Chief Business Officer", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chongdong  Fu", "title": "Senior VP & Head of CMC", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Charmayne  Chan", "age": 40, "title": "Company Secretary", "yearBorn": 1984, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 21.95, "open": 22.65, "dayLow": 22.52, "dayHigh": 23.37, "regularMarketPreviousClose": 21.95, "regularMarketOpen": 22.65, "regularMarketDayLow": 22.52, "regularMarketDayHigh": 23.37, "payoutRatio": 0.0, "beta": 1.049, "volume": 70208, "regularMarketVolume": 70208, "averageVolume": 129465, "averageVolume10days": 32840, "averageDailyVolume10Day": 32840, "bid": 21.48, "ask": 22.23, "bidSize": 1, "askSize": 1, "marketCap": 2007629696, "fiftyTwoWeekLow": 16.5, "fiftyTwoWeekHigh": 23.37, "priceToSalesTrailing12Months": 2.0472438, "fiftyDayAverage": 19.060425, "twoHundredDayAverage": 19.060425, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 7614303232, "forwardPE": 15.0229845, "profitMargins": -0.41342998, "floatShares": 175434321, "sharesOutstanding": 87066600, "sharesShort": 68178, "sharesShortPriorMonth": 101892, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0016, "shortRatio": 1.15, "impliedSharesOutstanding": 88950704, "bookValue": 0.846, "priceToBook": 27.234043, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -405432992, "trailingEps": -0.74, "enterpriseToRevenue": 7.765, "enterpriseToEbitda": -25.412, "52WeekChange": 0.32566166, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 23.04, "targetHighPrice": 27.0, "targetLowPrice": 27.0, "targetMeanPrice": 27.0, "targetMedianPrice": 27.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 1261211008, "totalCashPerShare": 4.038, "ebitda": -299628992, "totalDebt": 1668497024, "quickRatio": 1.152, "currentRatio": 1.264, "totalRevenue": 980649984, "debtToEquity": 608.581, "revenuePerShare": 12.988, "returnOnAssets": -0.09251001, "returnOnEquity": -2.35317, "grossProfits": 951564992, "revenueGrowth": 0.979, "grossMargins": 0.97033995, "ebitdaMargins": -0.30554, "operatingMargins": -3.61231, "financialCurrency": "CNY", "symbol": "AAPG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 4.965832, "regularMarketPrice": 23.04, "marketState": "PRE", "shortName": "Ascentage Pharma Group Internat", "corporateActions": [], "regularMarketTime": 1743537601, "exchange": "NGM", "messageBoardId": "finmb_620569787", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": 1.0900002, "regularMarketDayRange": "22.52 - 23.37", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 129465, "fiftyTwoWeekLowChange": 6.540001, "fiftyTwoWeekLowChangePercent": 0.3963637, "fiftyTwoWeekRange": "16.5 - 23.37", "fiftyTwoWeekHighChange": -0.32999992, "fiftyTwoWeekHighChangePercent": -0.0141206635, "fiftyTwoWeekChangePercent": 32.566166, "earningsTimestamp": 1743073227, "earningsTimestampStart": 1743073227, "earningsTimestampEnd": 1743073227, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.74, "epsCurrentYear": -2.40432, "priceEpsCurrentYear": -9.582751, "fiftyDayAverageChange": 3.979576, "fiftyDayAverageChangePercent": 0.20878738, "twoHundredDayAverageChange": 3.979576, "twoHundredDayAverageChangePercent": 0.20878738, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1737729000000, "displayName": "Ascentage Pharma", "trailingPegRatio": null}